Patient benefit-risk in arthritis--a rheumatologist's perspective.

Rheumatology (Oxford, England)

Volumn 49 Suppl 2, Issue , 2010, Pages

  Bijlsma, Johannes W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTHRITIS; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; METHODOLOGY; REVIEW; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE 2 INHIBITORS; GASTROINTESTINAL DISEASES; HUMANS; KIDNEY DISEASES; RISK ASSESSMENT;

EID: 77955702235     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq057     Document Type: Review

References (0)